GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JFL Life Sciences Ltd (NSE:JFLLIFE) » Definitions » EV-to-FCF

JFL Life Sciences (NSE:JFLLIFE) EV-to-FCF : 34.16 (As of Apr. 17, 2025)


View and export this data going back to 2022. Start your Free Trial

What is JFL Life Sciences EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, JFL Life Sciences's Enterprise Value is ₹772.6 Mil. JFL Life Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ₹22.6 Mil. Therefore, JFL Life Sciences's EV-to-FCF for today is 34.16.

The historical rank and industry rank for JFL Life Sciences's EV-to-FCF or its related term are showing as below:

NSE:JFLLIFE' s EV-to-FCF Range Over the Past 10 Years
Min: -6.4   Med: 28.29   Max: 135.19
Current: 31.76

During the past 6 years, the highest EV-to-FCF of JFL Life Sciences was 135.19. The lowest was -6.40. And the median was 28.29.

NSE:JFLLIFE's EV-to-FCF is ranked worse than
61.36% of 546 companies
in the Drug Manufacturers industry
Industry Median: 23.125 vs NSE:JFLLIFE: 31.76

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-17), JFL Life Sciences's stock price is ₹21.70. JFL Life Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹1.003. Therefore, JFL Life Sciences's PE Ratio (TTM) for today is 21.64.


JFL Life Sciences EV-to-FCF Historical Data

The historical data trend for JFL Life Sciences's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JFL Life Sciences EV-to-FCF Chart

JFL Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF
Get a 7-Day Free Trial - - - -4.79 21.64

JFL Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF Get a 7-Day Free Trial - - - -4.79 21.64

Competitive Comparison of JFL Life Sciences's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, JFL Life Sciences's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JFL Life Sciences's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JFL Life Sciences's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where JFL Life Sciences's EV-to-FCF falls into.


;
;

JFL Life Sciences EV-to-FCF Calculation

JFL Life Sciences's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=772.581/22.614
=34.16

JFL Life Sciences's current Enterprise Value is ₹772.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. JFL Life Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ₹22.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JFL Life Sciences  (NSE:JFLLIFE) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

JFL Life Sciences's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=21.70/1.003
=21.64

JFL Life Sciences's share price for today is ₹21.70.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. JFL Life Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹1.003.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


JFL Life Sciences EV-to-FCF Related Terms

Thank you for viewing the detailed overview of JFL Life Sciences's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


JFL Life Sciences Business Description

Traded in Other Exchanges
N/A
Address
Jodhpur Cross Road, 309, Satyam Mall, Opposite Saman Complex, Near Vishweshwar Mahadev Mandir, Settelite, Ahmedabad, GJ, IND, 380015
JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.

JFL Life Sciences Headlines

No Headlines